DNA Technology Screens Workers' Comp Claims

Bruce Gillis, M.D., M.P.H., medical toxicologist and CEO of The Cytokine Institute research group, recently presented a tutorial on new genomics-based technology called msds1and how it will impact workers’ compensation claims at the International Congress of Toxicology in Montreal.

The technology analyzes gene expression and how 36,000 parameters of an individual’s DNA are affected by exposure to chemicals, such as benzene or asbestos. Msds1 can determine with 99.9 percent certainty if a person was exposed to dangerous levels of a particular toxin, providing an impartial methodology for producing scientifically-based evidence to help reduce fraudulent claims.